Since the discovery in these laboratories of BRL 36650 (1)°, a C(6)-a-formamidopenicillin containing an N(4)-ethylpiperazine-2,3-dione group in the C(6)-/3-side chain, we have continued to search for new C(6)-a-formamidopenicillins/C(7)-o:-formamidocephalosporins2~7)
with an expanded spectrum of antibacterial activity when compared with 1. One outcome has been the synthesis of C(7)-aformamidocephalosporins of type (14)r). In common with BRL 36650 (1), 14 is a potent, /3-lactamasestable antibiotic, particularly active against Pseudomonas species8). The structural similarities between 1 and 14 are apparent, not only in the C(6)/C(7)-a:-formamido substituents, but also in the C(6)/C(7)-/3-side chains, both of which contain a catecholic amino acid residue acylated with the N(4)-ethylpiperazine-2, 3 -dione radical. Our early attempts at producing C(6)/C(7)-a-formamido analogues of 1 and 14 with improved biological properties, involved the replacement of the catechol and/or the piperazine-2,3-dione groups2~5). No new compounds with significantly enhanced activity against either Gram-positive or Gram-negative bacteria were obtained. Similarly, modification of the piperazine-2,3-dione moiety itself, by substitution at the C(5) or C(6) carbon atoms9), did not produce any derivatives with advantages over BRL 36650 (1).
Wenow report the preparation of analogues of 1 and 14 with improved antibacterial potency and/or an expanded spectrum of biological activity, having varying substituents at N(4) of the piperazine-2,3-dione ring.
Chemistry
The synthesis of the C(6)-a-substituted penicillins (2~9, ll and 12) is shown in Scheme 19>1O). The C(6)-unsubstituted penicillin (10) was prepared by a simple Schotten-Baumann acylation of ampicillinn). The catecholic hydroxyl groups in the N(4)-substituents were protected as benzyl ethers and deprotected by catalytic hydrogenation as shown. The acetate protecting groups in penicillins (2 and 3) are known to be labile9) and were not removed.
The cephalosporins (15~17) were prepared by methods developed in these laboratories12*1^
and are illustrated in Scheme 2. The catecholic hydroxyl groups were protected as acetates and, because of the uncertainty of their stability, deprotected by hydrolysis with citrus acetyl esterase at neutral pH7).
Results and Discussion
Replacement of the N(4)-ethyl substituent by the more lipophilic phenyl or benzyl groups, gave compounds of similar 2 or slightly lower activity 3 (see Table 1 ). However, the R and Rx substituents in 2 could be interchanged to give a new derivative 4 without significantly affecting the antibacterial activity. The higher homologues, 5 and 6, were likewise potent anti-Gram-negative agents, 5 being slightly more active than BRL36650 (1) itself. The isomeric 2,3-dihydroxy analogue (7) and the bioisosteric pyridone (8) were also highly active antibiotics, although the latter showed poor activity against Streptococcus pyogenes and cefotaxime-resistant Serratia marcescens HCN 3956. The incorporation of a second catechol group into the phenylglycyl residue of 5, gave the analogue ll, which showed no further improvement in activity over the phenyl (5) or 4-hydroxyphenyl (12) derivatives. Replacement of the C(6)-a-formamido substituent in 5 with a methoxy group, gave penicillin 9, which exhibited rather poor activity against Proteus mirabilis and cephalosporinase-producing Enterobacteriaceae. However, the necessity of a C(6)-a-substituent for /3-lactamase stability, was clearly Scheme 1 demonstrated by comparing the activities of 5 and 10. Similar results were obtained in the cephalosporin series. For example, the antibacterial activity of 16, or the corresponding 7V-methyltetrazole analogue (17), both incorporating a catechol group in the diketopiperazine N(4)-substituent, was similar to that of cephalosporin (14), in which the catechol Scheme 2. resided in the phenylglycyl portion of the C(7)-/3-side chain. Indeed, the Gram-positive activity of 16 was slightly improved compared with 14. The best Gram-positive activity, however, was seen in the cephalosporins lacking a C(7)-a-substituent, 15 and 18. Unfortunately, 15 and 18 showed poor activity against Gram-negative bacteria producing class I^-lactamases constitutively.
Conclusion
The introduction of a catechol-containing group into the N(4)-substituent of penicillins and cephalosporins containing a piperazine-2,3-dione moiety in the C(6)/C(7)-/3-side chain, led to compounds with potent Gram-negative activity.
Experimental
Analytical and general experimental techniques are as described in our earlier paper9).
4-(3,4-Dibenzyloxybenzyl)-2,3-dioxopiperazine13) (416 mg, 1 mmol) was converted to its carbonyl chloride by known methods9) and used to acylate sodium ampicillin (371 mg, 1 mmol) under standard conditions12). The product from above was hydrogenated in saturated, aqueous sodium hydrogen carbonate in the usual manner9) and the title compoundisolated, after treatment with sodium 2-ethylhexanoate in 4-methylpentan- 
4-(3,4-Dibenzyloxybenzyl)-2,3-dioxopiperazin-l-ylcarbonyl chloride (478.5 mg, 1 mmol) (prepared as described above) was used to acylate benzyl 6i5-[D-2-amino-2-phenylacetamido]-6a-methylthiopenicillanate (485 mg, 1 mmol) in the normal manner9). Work up and chromatography (50% EtOAccyclohexane) gave benzyl 6i8- [D-2-[4-(3 ,4-dibenzyloxybenzyl with 0.001 ml of an overnight broth culture diluted 1/100 (approx 104 cfu/spot). AUG. 1989 thioglycerol) m/z 928 (M+H, C50H49N5O9S2). The above ester was converted by known methods0 to benzyl 6/3- [D-2-[4-(3,4-dibenzyloxybenzyl Use of methanol10) in the above displacement instead of ammonia gave the C(6)-a-methoxyanalogue, which was progressed as described below to give 9.
The benzyl protecting groups were removed by hydrogenation and the title compound (160 mg, 79 %) isolated by filtration, after treatment with sodium 2-ethylhexanoate in 4-methylpentan-2-one:
IR ( 
Similarly, the /?-hydroxy analogue (12) was prepared from benzyl 6/3-[D-2-amino-2-
Treatment of l-(3,4-dihydroxybenzyl)-2,3-dioxopiperazine13) (236 mg, 1.05 mmol) with trichloromethyl chloroformate in the usual manner9) and reaction of the product with 3-acetoxy-7/3-[D-2-amino-2-phenylacetamido]cephalosporanic acid (219 mg, 1 mmol) under standard conditions10 gave the title compound (419 mg, 61 %), after treatment with sodium 2-ethylhexanoate in 4-methylpentan-2- purified by chromatography (90% EtOAc -cyclohexane) and the ester protecting group removed with TFAand anisole4). Removalof the acetate protecting groups with citrus acetyl esterase70, gave the title compound (102 mg, 32%) after chromatography (THF -water, 0 to 50% gradient) : IR (KBr) 
